Exosome-cargoed microRNAs: Potential therapeutic molecules for diabetic wound healing
- PMID: 35868627
- DOI: 10.1016/j.drudis.2022.07.008
Exosome-cargoed microRNAs: Potential therapeutic molecules for diabetic wound healing
Abstract
Diabetic foot ulcers are one of the most common complications of diabetes, requiring repeated surgical intervention and leading to amputation. Owing to the lack of effective drugs, novel therapeutics need to be explored. Decreased angiogenic factors, endothelial cell dysfunction and vascular lumen stenosis impair angiogenesis in diabetic wounds. Exosome-cargoed microRNAs are emerging as pivotal regulators of angiogenesis during wound closure. Herein, we summarize the up-to-date knowledge of exosomal microRNAs in modulating angiogenesis and accelerating diabetic wound healing, as well as their targets and underlying mechanisms. Exosomal microRNAs could be therapeutics with negligible rejection complications and good compatibility to treat diabetic foot ulcers.
Keywords: Angiogenesis; Diabetic foot ulcers; Exosomes; MicroRNAs; Wound healing.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Similar articles
-
Role of exosome-derived miRNAs in diabetic wound angiogenesis.Mol Cell Biochem. 2024 Oct;479(10):2565-2580. doi: 10.1007/s11010-023-04874-1. Epub 2023 Oct 27. Mol Cell Biochem. 2024. PMID: 37891446 Review.
-
Exosomal IRF1-loaded rat adipose-derived stem cell sheet contributes to wound healing in the diabetic foot ulcers.Mol Med. 2023 Apr 25;29(1):60. doi: 10.1186/s10020-023-00617-6. Mol Med. 2023. PMID: 37098476 Free PMC article.
-
Exosomal ncRNAs: The pivotal players in diabetic wound healing.Front Immunol. 2022 Nov 7;13:1005307. doi: 10.3389/fimmu.2022.1005307. eCollection 2022. Front Immunol. 2022. PMID: 36420273 Free PMC article. Review.
-
A synthetic microRNA-92a inhibitor (MRG-110) accelerates angiogenesis and wound healing in diabetic and nondiabetic wounds.Wound Repair Regen. 2018 Jul;26(4):311-323. doi: 10.1111/wrr.12660. Epub 2018 Oct 22. Wound Repair Regen. 2018. PMID: 30118158
-
Angio-microRNAs in diabetic foot ulcer-: Mechanistic insights and clinical perspectives.Prog Biophys Mol Biol. 2024 Oct;192:1-10. doi: 10.1016/j.pbiomolbio.2024.07.006. Epub 2024 Jul 27. Prog Biophys Mol Biol. 2024. PMID: 39069213 Review.
Cited by
-
Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.Int J Nanomedicine. 2023 Dec 23;18:7923-7940. doi: 10.2147/IJN.S444582. eCollection 2023. Int J Nanomedicine. 2023. PMID: 38152837 Free PMC article. Review.
-
Effects of Intensive Glycemic Control on Serum Exosome miR-126-3p and miR-125b-1-3p Levels and Wound Healing in Patients with Diabetic Ulcers.Evid Based Complement Alternat Med. 2023 Jan 30;2023:2523245. doi: 10.1155/2023/2523245. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 36756041 Free PMC article.
-
Single-cell profiling reveals transcriptomic signatures of vascular endothelial cells in non-healing diabetic foot ulcers.Front Endocrinol (Lausanne). 2023 Dec 1;14:1275612. doi: 10.3389/fendo.2023.1275612. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38107519 Free PMC article.
-
Exosomes: compositions, biogenesis, and mechanisms in diabetic wound healing.J Nanobiotechnology. 2024 Jul 5;22(1):398. doi: 10.1186/s12951-024-02684-1. J Nanobiotechnology. 2024. PMID: 38970103 Free PMC article. Review.
-
Exosomal miRNA-155-5p from M1-polarized macrophages suppresses angiogenesis by targeting GDF6 to interrupt diabetic wound healing.Mol Ther Nucleic Acids. 2023 Nov 10;34:102074. doi: 10.1016/j.omtn.2023.102074. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 38074896 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical